(d) Risk characterisation
The estimation of the incidence and severity of the adverse effects likely to occur in a human population, animals or environmental compartments due to actual or predicted exposure to any active substance or substance of concern in a biocidal product. This may include ‘risk estimation’, i.e. the quantification of that likelihood.
← anx_VI__cpt_1__cpt_1__cpt_1__cpt_3__text_1 · All articles · anx_VI__cpt_1__cpt_1__cpt_1__cpt_4__text_1 →
Source: EUR-Lex (Cellar) · retrieved 2026-10-29 · Text as adopted (Official Journal); later amendments are not incorporated in this text.